{"id":"https://openalex.org/W2740296199","doi":"https://doi.org/10.1158/1538-7445.am2017-951","title":"Abstract 951: Induction of COX-2 and NF\u03baB activation represent TLR3-independent undesirable aspects of poly-I:C activity","display_name":"Abstract 951: Induction of COX-2 and NF\u03baB activation represent TLR3-independent undesirable aspects of poly-I:C activity","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2740296199","doi":"https://doi.org/10.1158/1538-7445.am2017-951","mag":"2740296199"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-951","doi":"https://doi.org/10.1158/1538-7445.am2017-951","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-951","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086172508","display_name":"Marie\u2010Nicole Theodoraki","orcid":"https://orcid.org/0000-0002-5491-1593","observed_orcids":["https://orcid.org/0000-0002-5491-1593"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marie-Nicole Theodoraki","raw_affiliation_strings":["1University of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075845241","display_name":"Ravi Muthuswamy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Muthuswamy","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024411462","display_name":"Jamie Voyten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Voyten","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076251961","display_name":"Francesmary Modugno","orcid":"https://orcid.org/0000-0003-0637-1534","observed_orcids":["https://orcid.org/0000-0003-0637-1534"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesmary Modugno","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086417927","display_name":"Nata\u0161a Obermajer","orcid":"https://orcid.org/0000-0002-0838-7508","observed_orcids":["https://orcid.org/0000-0002-0838-7508"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natasa Obermajer","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070555068","display_name":"Robert P. Edwards","orcid":"https://orcid.org/0000-0003-0370-1390","observed_orcids":["https://orcid.org/0000-0003-0370-1390"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert P. Edwards","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057788524","display_name":"Pawe\u0142 Kali\u0144ski","orcid":"https://orcid.org/0000-0001-7025-3562","observed_orcids":["https://orcid.org/0000-0001-7025-3562"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pawel Kalinski","raw_affiliation_strings":["2University fo Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University fo Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I170201317"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"951","last_page":"951"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.32760000228881836,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.32760000228881836,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.24220000207424164,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.20649999380111694,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/poly-i-c","display_name":"poly(I:C)","score":0.9020000100135803},{"id":"https://openalex.org/keywords/tlr3-ligand","display_name":"TLR3 ligand","score":0.8899999856948853},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.8240000009536743},{"id":"https://openalex.org/keywords/nf-kappab-activation","display_name":"NF-\u03baB activation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.953000009059906},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.878000020980835},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ccl22","display_name":"CCL22","score":0.8790000081062317},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.824999988079071},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.7429999709129333},{"id":"https://openalex.org/keywords/adjuvants","display_name":"adjuvants","score":0.5860000252723694},{"id":"https://openalex.org/keywords/chemotaxis","display_name":"chemotaxis","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2778420691","wikidata":"https://www.wikidata.org/wiki/Q14866230","display_name":"TLR3","level":5,"score":0.6319701075553894},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.6227898597717285},{"id":"https://openalex.org/C134678942","wikidata":"https://www.wikidata.org/wiki/Q3776878","display_name":"CCL22","level":5,"score":0.618899405002594},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.557131290435791},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5501476526260376},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5480773448944092},{"id":"https://openalex.org/C116484652","wikidata":"https://www.wikidata.org/wiki/Q3492926","display_name":"CCL5","level":5,"score":0.5307198762893677},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5129749178886414},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5115697979927063},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.4804482161998749},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4703018069267273},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4511309862136841},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.44798120856285095},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.43597960472106934},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40606775879859924},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3809869885444641},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3595529794692993},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.31510359048843384},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.30846524238586426},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.16834375262260437},{"id":"https://openalex.org/C2776709828","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll-like receptor","level":4,"score":0.1330559253692627},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.12336745858192444},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11949959397315979},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.10845685005187988},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-951","doi":"https://doi.org/10.1158/1538-7445.am2017-951","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-951","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2968205824","https://openalex.org/W4313385763","https://openalex.org/W1968955362","https://openalex.org/W2945982948","https://openalex.org/W2752977230","https://openalex.org/W2150819177","https://openalex.org/W2807061369","https://openalex.org/W2417221274","https://openalex.org/W2404729303","https://openalex.org/W2946230969"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Infiltration":[2],"of":[3,47,62,73,78,111,118,126,198,226,236,242,263,278,291,330,337,340,378,410,419,425],"cytotoxic":[4],"T-cells":[5,25,177],"(CTL)":[6],"in":[7,52,108,167,260,282,310,316],"tumors":[8],"is":[9],"known":[10],"to":[11,43,95,194,257,284],"be":[12,258,374,385],"associated":[13],"with":[14,23,64,295,313],"improved":[15],"patient\u2019s":[16],"clinical":[17],"outcomes.":[18],"In":[19],"contrast,":[20],"local":[21],"infiltration":[22],"regulatory":[24],"(Treg)":[26],"predicts":[27],"accelerated":[28],"progression":[29],"and":[30,76,80,100,128,141,149,180,212,244,297,305,307,319,347,366,412],"shorter":[31],"overall":[32],"survival.":[33],"The":[34,321],"above":[35],"observations":[36],"highlight":[37],"the":[38,59,91,109,183,196,224,227,251,261,289,301,317,335,353,426],"need":[39],"for":[40,138,146,352,429],"new":[41],"measures":[42],"promote":[44],"selective":[45,66,338,361,389],"accumulation":[46],"CTLs":[48],"but":[49,220,265,358],"not":[50,221,266,359],"Tregs":[51],"tumor":[53,97,311],"microenvironments":[54],"(TME).":[55],"Here":[56],"we":[57,88],"compare":[58],"TME-modulating":[60],"impact":[61,197],"poly-I:C":[63,123,219,239,264,420],"a":[65,276,360,379,388],"TLR3":[67,121,127,133,362,390],"ligand,":[68,363],"rintatolimod":[69,131,222],"showing":[70],"an":[71],"induction":[72],"CCL22,":[74],"CXCL12":[75],"expression":[77,225,241,329],"COX-2":[79,243,252,411],"downstream":[81],"suppressive":[82,246,369],"factors,":[83,370],"selectively":[84,281,299],"by":[85,234],"poly-I:C.":[86,285],"Finally,":[87],"report":[89],"on":[90],"optimized":[92],"combinatorial":[93],"adjuvant":[94],"reprogram":[96],"microenvironment.":[98],"Materials":[99],"Methods:":[101],"Twelve":[102],"ovarian":[103,154,186,322],"cancer":[104,155,187,323],"specimens":[105],"were":[106,136,144,165,172,192,207],"cultured":[107],"presence":[110,262],"IFN\u03b1,":[112],"indometacin":[113],"(COX-1/2":[114],"inhibitor)":[115],"or/and":[116],"one":[117],"two":[119],"synthetic":[120],"ligands,":[122],"(non-selective":[124],"activator":[125],"helicases)":[129],"or":[130,162],"(selective":[132],"ligand).":[134],"Biopsies":[135],"harvested":[137],"mRNA":[139],"measurements":[140],"culture":[142],"supernatants":[143,181],"analyzed":[145],"CCL5,":[147],"CXCL10":[148,306],"CCL22":[150,309],"concentrations.":[151],"Alternatively,":[152],"established":[153],"cell":[156,324],"lines,":[157],"monocyte-derived":[158],"macrophages,":[159],"THP1":[160],"cells":[161],"adult":[163],"fibroblasts":[164],"used":[166,193],"analogous":[168],"experiments.":[169],"Chemotaxis":[170],"assays":[171],"performed":[173],"using":[174,202,342,387],"pre-activated":[175],"CD8+":[176],"(top":[178],"chamber)":[179],"from":[182],"differentially":[184],"treated":[185],"specimens.":[188],"Western":[189,269],"blot":[190],"experiments":[191,201],"evaluate":[195],"NF\u03baB.":[199],"Blocking":[200],"soluble":[203],"TNF\u03b1":[204,254],"receptor":[205],"inhibitor":[206],"performed.":[208],"Results:":[209],"Both,":[210],"Poly-I:C":[211],"rintatolimod,":[213],"induced":[214,240,300],"CTL":[215],"attractant":[216,229],"CXCL10.":[217],"Unexpectedly,":[218],"promoted":[223],"MDSC/Treg":[228],"CXCL12,":[230],"which":[231,371],"was":[232,255],"reversed":[233],"addition":[235,377],"indometacin.":[237],"Furthermore,":[238],"COX-2-dependent":[245],"factors":[247,346],"(IDO,":[248],"IL-10).":[249],"Evaluating":[250],"cascade,":[253],"found":[256],"increased":[259],"rintatolimod.":[267],"Additionally,":[268],"Blot":[270],"analysis":[271],"showed":[272,326],"I-\u03baB":[273],"degradation":[274],"(as":[275],"marker":[277],"NF-\u03baB":[279],"activation),":[280],"response":[283],"We":[286,333,350],"observed":[287],"that":[288,356],"combination":[290],"both":[292],"TLR-3":[293],"ligands":[294],"IFN\u03b1":[296],"indomethacin":[298],"desirable":[302],"chemokines":[303],"CCL5":[304],"suppressed":[308],"samples":[312],"similar":[314],"results":[315],"macrophages":[318],"fibroblasts.":[320],"lines":[325],"only":[327],"minimal":[328],"chemokines.":[331],"Conclusion:":[332],"demonstrate":[334],"feasibility":[336],"modulation":[339],"TME,":[341],"different":[343],"clinically":[344],"applicable":[345],"their":[348],"combinations.":[349],"show":[351],"first":[354],"time,":[355],"poly-I:C,":[357],"induces":[364],"NF\u03baB":[365,413],"undesirable":[367,417],"COX2-dependent":[368],"though":[372],"can":[373],"eliminated":[375],"through":[376],"COX-1/2":[380],"inhibitor.":[381],"These":[382],"effects":[383],"may":[384],"avoided":[386],"ligand.":[391],"Citation":[392],"Format:":[393],"Marie-Nicole":[394],"Theodoraki,":[395],"Ravi":[396],"Muthuswamy,":[397],"Jamie":[398],"Voyten,":[399],"Francesmary":[400],"Modugno,":[401],"Natasa":[402],"Obermajer,":[403],"Robert":[404],"P.":[405],"Edwards,":[406],"Pawel":[407],"Kalinski.":[408],"Induction":[409],"activation":[414],"represent":[415],"TLR3-independent":[416],"aspects":[418],"activity":[421],"[abstract].":[422],"In:":[423],"Proceedings":[424],"American":[427],"Association":[428],"Cancer":[430,443],"Research":[431],"Annual":[432],"Meeting":[433],"2017;":[434],"2017":[435],"Apr":[436],"1-5;":[437],"Washington,":[438],"DC.":[439],"Philadelphia":[440],"(PA):":[441],"AACR;":[442],"Res":[444],"2017;77(13":[445],"Suppl):Abstract":[446],"nr":[447],"951.":[448],"doi:10.1158/1538-7445.AM2017-951":[449]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2017-08-08T00:00:00"}